The subject of the order is the delivery of medicinal products under the therapeutic health program and pharmaceutical products divided into 7 parts

Adalimumabum 0.04 g/0.8 ml

Rituximabum 500 mg/50 ml

Tocilizumab inj. 0.4g/20 ml and 0.08g/4 ml

Baricitinibum, 4 mg, tabl. powl.

Ethanerceptum 0,05 g/ml

Tofacitinibum 5 mg, tabl. powl.

Linezolide, 2mg/ml